CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Control Bionics Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Control Bionics Ltd
Suite 5.01, 697 Burke Road, Camberwell
Phone: +61 398973576p:+61 398973576 SYDNEY, VIC  3124  Australia Ticker: CBLCBL

Business Summary
Control Bionics Limited is a medical device company engaged in the development, commercialization and sale of assistive communications technology systems within the disability sector. It assists patients whose ability to communicate verbally or through text and social media is compromised by illnesses, such as motor neuron disease, amyotrophic lateral sclerosis, and others. Its NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as Electromyography output. This output is then sent wirelessly through the NeuroNode to a personal computer, enabling speech and other computer-controlled functions, such as email and texting. Its core systems include NeuroNode Trilogy, NeuroNode Duo, Eye-gaze Duo, and DROVE. Its technology is integrated with eye-gaze technology, whereby the eye gaze enables a cursor to be moved on a computer screen, driven like a mouse, and the NeuroNode acts like the mouse button.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20236/30/2023Yes----

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Independent Chairman of the Board Roger D.Hawke
Chief Executive Officer, Director JeremySteele 1/19/2023 1/19/2023
Founder, Executive Director Peter ShannFord
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 144,871,544 (As of 12/31/2023)
Stock Exchange: ASX


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024